Blog
RSS FeedPosted by Michael Wonder on 23 Nov 2016
CADTH recommends listing of Quinsair
23 November 2016 - CADTH recommends use of levofloxacin inhalation solution. ...
Posted by Michael Wonder on 21 Nov 2016
Consultation on CADTH’s proposed process for the assessment of companion diagnostics
21 November 2016 - CADTH is inviting stakeholder comments and feedback on the following proposed process for the assessment of companion ...
Posted by Michael Wonder on 02 Nov 2016
Jardiance recommended by CADTH for use by patients with type 2 diabetes mellitus at high risk of cardiovascular disease
26 October 2016 - CADTH publishes final recommendation on prevention of cardiovascular mortality in type 2 diabetes mellitus. ...
Posted by Michael Wonder on 01 Nov 2016
CADTH supports the use of Entyvio in Crohn's disease
31 October 2016 - Takeda's Entyvio clocks up another CADTH recommendation. ...
Posted by Michael Wonder on 30 Oct 2016
CADTH recommends the reimbursement of Taltz
25 October 2016 - The CADTH CDEC has recommend that ixekizumab be reimbursed for patients with moderate to severe plaque ...
Posted by Michael Wonder on 26 Oct 2016
Update to CADTH Guidelines for the Economic Evaluation of Health Technologies
27 October 2016 - CADTH's current Guidelines for the Economic Evaluation of Health Technologies (3rd edition) were published in ...
Posted by Michael Wonder on 18 Oct 2016
CADTH calls for patient input on a submission for Zinbryta (daclizumab)
18 October 2016 - CADTH is calling for patient input on Biogen's submission for Zinbryta (daclizumab). ...
Posted by Michael Wonder on 12 Oct 2016
CADTH calls for patient input on submission from Servier for Corlovan
11 October - CADTH is calling for patient input on a submission from Servier for Corlovan (ivabradine hydrochloride). ...
Posted by Michael Wonder on 07 Oct 2016
CADTH calls for patient input on a submission from Celopharma for Mifegymiso
6 October 2016 - CADTH is calling for patient input on a submission from Celopharma for its combination product Mifegymiso. ...
Posted by Michael Wonder on 04 Oct 2016
Abortion-drug company open to restarting reimbursement review process
27 September 2016 - The company that is bringing the gold standard in abortion drugs to Canada says it is “open” ...
Posted by Michael Wonder on 01 Oct 2016
CADTH publishes initial recommendation for Afinitor (everolimus)
29 September 2016 - CADTH has published its initial recommendtation for Novartis' Afinitor. ...
Posted by Michael Wonder on 26 Sep 2016
Most provincial drug plans won’t cover abortion pills in Canada
26 September 2016 - When the gold standard in medical abortion drugs finally becomes available in Canada later this year, the ...
Posted by Michael Wonder on 24 Sep 2016
CADTH publishes final recommendation for Lenvima (lenvatinib mesylate)
20 September 2016 - CADTH has posted its final outcome for Eisai's Lenvima. ...
Posted by Michael Wonder on 22 Sep 2016
CADTH calls for patient input on a resubmission from NovoNordisk for Victoza (liraglutide)
21 September 2016 - CADTH is calling for patient input on a resubmission from Novo Nordisk for Victoza (liraglutide). ...
Posted by Michael Wonder on 16 Sep 2016
CADTH drug portfolio information sessions
16 September 2016 - The CADTH Drug Portfolio Information Sessions are an opportunity for stakeholders to receive an update on the ...